Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "ABI"

4514 News Found

WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center
News | June 23, 2026

WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center

Clearing 19 biologics for Europe market


KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute
Hospitals | June 23, 2026

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute

Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable


AbbVie to acquire Apogee in $10.9 billion immunology power play
Biopharma | June 23, 2026

AbbVie to acquire Apogee in $10.9 billion immunology power play

Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards


Pfizer CFO Dave Denton to exit
People | June 23, 2026

Pfizer CFO Dave Denton to exit

Pharma powerhouse names Cecile Guegan interim finance chief


AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy
Biopharma | June 23, 2026

AbbVie unveils 9-Yr CLL data showing lasting survival benefit for Venetoclax-based therapy

Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients


Zealand Pharma’s petrelintide delivers double-digit weight loss in next-gen obesity treatment
Clinical Trials | June 23, 2026

Zealand Pharma’s petrelintide delivers double-digit weight loss in next-gen obesity treatment

The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity


India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
interviews | June 22, 2026

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors


MICK Digital empanelled as AMTZ authorized channel partner
Medical Device | June 22, 2026

MICK Digital empanelled as AMTZ authorized channel partner

Partnership strengthens healthcare technology distribution capabilities, enabling wider reach of Make-in-India medical devices through government and institutional healthcare networks


Biopharma funding rebounds in 2026, but capital flows to lower-risk assets
Biopharma | June 22, 2026

Biopharma funding rebounds in 2026, but capital flows to lower-risk assets

M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges